4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-23-070804
Chief Executive Officer bought 19,000 shares at $2.76 ($52,440)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudley Robert Michael Chief Executive Officer | 2023-06-09 | Purchase | +19,000 | $2.76 | $52,440 | 912,114 | D |
| Open-market purchases · 19,000 sh · avg $2.76 · $52,440 | |||||||
Loading xslF345X04/tm2318573-1_4seq1.xml…